- With Photo
CRAWLEY, England, Sept. 20, 2012 /PRNewswire/ -- Her Majesty's Lord Lieutenant of West Sussex officially presented The Queen's Award for Enterprise 2012: International Trade to Elekta, a leading global medical technology company dedicated to oncology and neuroscience clinical advancements, on Fleming Way in Crawley on September 19.
Dignitaries representing The Queen, West Sussex County Council, Crawley Borough Council and local Crawley MP The Rt. Hon. Henry Smith MP attended the ceremonial presentation.
The Queen's Award, confirmed in April earlier this year, is the United Kingdom's highest accolade for business success, and acknowledges continuous improvement in Elekta's overseas sales. Elekta's steady growth of exports is calculated at 131 percent over the last six years.
In addition to The Queen's Award presentation the official party toured the Elekta site and participated in an informal reception.
"The presentation of The Queen's Award was a celebration of the skill and commitment of our staff and the support of valued customers at home and overseas," says Bill Yaeger, Executive Vice President Elekta Oncology. "Crawley is world renowned as the home of the digital linear accelerator, and we are pleased that Elekta's employees and clinical partners can be proud of The Queen's Award and in our tradition of improving the lives of individuals with cancer. Elekta's oncology innovations not only are shared with the world, but they also benefit the U.K. manufacturing and industrial sectors."
"The Queen's Award for International Trade is an important and prestigious endorsement of our business performance," he adds. "But that level of achievement is built on a broad combination of staff dedication, inspiration and relationships with hospitals throughout the world including thriving partnerships with NHS Trusts here in the U.K. We are truly grateful for everyone's support."
In May, The Rt. Hon. Iain Duncan Smith, British Secretary of State for Work and Pensions, visited Elekta's Crawley facility. His fact-finding trip offered a personal insight into Elekta's new high-resolution Agility™* 160-leaf multi-leaf collimator (MLC).
*Agility is not available for sale or distribution in all markets. Please contact the local Elekta representative for details.
For further information, please contact:
Johan Andersson Melbi, Investor Relations Manager, Elekta AB
Tel: +46 702 100 451, email: firstname.lastname@example.org
Time zone: CET: Central European Time
Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: email@example.com
Time zone: ET: Eastern Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.
Note to Editors: